Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2023 Q2- Text added to 2023 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
affordability, argument, Assembly, Babet, banker, began, Cencora, Colorado, committee, comprised, converted, Cork, deploying, equal, feature, Governor, hepatic, hoc, Ikena, indenture, Israel, mild, paused, premium, pretreated, redeem, redeemed, redemption, registered, semiannual, shift, Storm, temporarily, Tentarix, Tizona, unpaid, upper
Removed:
affirmed, agreed, analog, anticancer, anticipation, Circuit, confident, defending, dismissed, eliminated, enforceable, EPO, hearing, hemifumarate, hospitalization, inhibit, instituted, judgment, LBCL, Minnesota, nucleotide, occurred, opposing, opposition, Pharmasset, prove, putative, replication, restore, revocation, revoked, shortened, sofosbuvir, spent, strength, succeeding, upheld
Valuein 2023 Q2 filing- Value in 2023 Q3 filing
Original filings
Filing view